56 related articles for article (PubMed ID: 25162218)
1. LC-MS/MS and EMIT measure the whole blood concentration of cyclosporine A: The two methods yield concordant results within the dynamic range of the latter, but the former shows broader application scenarios.
Zhang YY; Guo HL; Wang J; Wang WJ; Li Y; Chu CC; Wu CY; Huang J; Hu YH; Chen F
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jun; 1240():124154. PubMed ID: 38749100
[TBL] [Abstract][Full Text] [Related]
2. Tacrolimus Monitoring in Liver Transplant Recipients, Posttransplant Cholestasis: A Comparative Between 2 Commercial Immunoassays and a Liquid Chromatography-Tandem Mass Spectrometry Method.
Parant F; Delignette MC; Charpiat B; Lacaille L; Lebosse F; Monneret G; Mohkam K; Mabrut JY; Aubrun F; Heyer L; Antonini T
Ther Drug Monit; 2024 Apr; ():. PubMed ID: 38648663
[TBL] [Abstract][Full Text] [Related]
3. Is the automated Elecsys tacrolimus assay on the Roche cobas e 602 analyzer an acceptable replacement for a liquid chromatography-tandem mass spectrometry-based assay?
Gant Kanegusuku A; Yeo KJ
Am J Clin Pathol; 2024 Jan; 161(1):97-106. PubMed ID: 37724434
[TBL] [Abstract][Full Text] [Related]
4. Determination of tacrolimus in human whole blood in kidney transplant recipients using a rapid and specific LC-MS/MS method.
Hieu TB; Dung NM; Toan PQ; Kien TQ; Van Duc N; Thang LV; Van Tran P; Hop VQ; Phuong NM; Ben NH; Van Khoi N; Nghia TT; Dung VD; Van Thinh N; Hang DTT; Van Men C; Long DD; Su HX
J Clin Lab Anal; 2023 Aug; 37(15-16):e24958. PubMed ID: 37621139
[TBL] [Abstract][Full Text] [Related]
5.
Dasgupta A; Woodard K; Ramoo B; Frazee C; Garg U
Ann Clin Lab Sci; 2024 Mar; 54(2):258-261. PubMed ID: 38802160
[TBL] [Abstract][Full Text] [Related]
6. [Determination of Plasma Concentrations of Imatinib by a Novel Automated Analyzer Based on High-Performance Liquid Chromatography].
Fukushi Y; Akamine Y; Matsushita M; Morikawa S; Miura M
Yakugaku Zasshi; 2023; 143(11):963-969. PubMed ID: 37914342
[TBL] [Abstract][Full Text] [Related]
7. Stability and Analytical Characterization of Voriconazole as Measured by Immunoassay.
Bharti V; Jung B; Lam S; Fabros A; Selvaratnam R
J Appl Lab Med; 2024 May; 9(3):565-572. PubMed ID: 38366039
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Busulfan as a Third-Party Immunoassay on a Clinical Chemistry Analyzer.
Zhou JR; To A; Fritz J; Jung B; Yazdanpanah M; Kulasingam V
J Appl Lab Med; 2024 May; 9(3):549-557. PubMed ID: 38332638
[TBL] [Abstract][Full Text] [Related]
9. Comparison of whole-blood sirolimus concentrations measured by EMIT-based Siemens Viva-ProE® System and LC-MS/MS in Chinese transplant patients.
Lin R; Cai Y; Huang Y; Li X; Chen Y; Chen B; Lai K; Wu J; Cheng Y; Liu M; Chen Y; Qiu H
J Pharm Biomed Anal; 2024 Jun; 247():116271. PubMed ID: 38850850
[TBL] [Abstract][Full Text] [Related]
10. Interlaboratory Analysis of Isavuconazole Plasma Concentration Assays Among European Laboratories.
Pea F; Krause R; Müller C; Hennart B; Richardson M; Meinitzer A; Wiesen MHJ; Wiktorowicz T; Spickermann J; Henriksen AS
Ther Drug Monit; 2019 Oct; 41(5):657-664. PubMed ID: 31568234
[TBL] [Abstract][Full Text] [Related]
11. Comparison of assay methods for quantifying sex hormone concentrations across the menstrual cycle in rhesus macaques.
Fecteau KM; Winchell AJ; Blue SW; Appleman ML; Urbanski HF; Erikson DW
Biol Reprod; 2024 Apr; ():. PubMed ID: 38685627
[TBL] [Abstract][Full Text] [Related]
12. Validation of an automated sample preparation module directly connected to LC-MS/MS (CLAM-LC-MS/MS system) and comparison with conventional immunoassays for quantitation of tacrolimus and cyclosporin A in a clinical setting.
Shimada T; Kawakami D; Fujita A; Yamamoto R; Hara S; Ito K; Mizushima I; Kitajima S; Iwata Y; Sakai N; Kawano M; Wada T; Sai Y
J Pharm Health Care Sci; 2024 Jan; 10(1):5. PubMed ID: 38191469
[TBL] [Abstract][Full Text] [Related]
13. Standardization of PTH measurement by LC-MS/MS: a promising solution for interassay variability.
Nakagawa Y; Komaba H
Kidney Int; 2024 Feb; 105(2):244-247. PubMed ID: 38245214
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a bioanalytical assay for the measurement of total and unbound teicoplanin in human serum.
Mouton JWA; Raaijmakers J; Botterblom M; Toonen M; Ter Heine R; Smeets RL; Brüggemann RJM; Te Brake L; Jager NGL
J Antimicrob Chemother; 2023 Nov; 78(11):2723-2730. PubMed ID: 37757461
[TBL] [Abstract][Full Text] [Related]
15. Long-term cross-validation of everolimus therapeutic drug monitoring assays: the Zortracker study.
Schniedewind B; Niederlechner S; Galinkin JL; Johnson-Davis KL; Christians U; Meyer EJ
Ther Drug Monit; 2015 Jun; 37(3):296-303. PubMed ID: 25970506
[TBL] [Abstract][Full Text] [Related]
16. Comparison of everolimus QMS immunoassay on Architect ci4100 and liquid chromatography/mass spectrometry: lack of agreement in organ-transplanted patients.
Hoffer E; Kurnik D; Efrati E; Scherb I; Karasik M; Ring G; Bentur Y
Ther Drug Monit; 2015 Apr; 37(2):214-9. PubMed ID: 25162218
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of QMS everolimus assay using Indiko analyzer: comparison with an ultra-performance liquid chromatography-tandem mass spectrometry method.
Buthiau D; Bargnoux AS; Badiou S; Sutra T; Dupuy AM; Pageaux GP; Mourad G; Cristol JP
Ther Drug Monit; 2015 Apr; 37(2):275-8. PubMed ID: 25254414
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Drug Monitoring of Everolimus: Comparability of Concentrations Determined by 2 Immunoassays and a Liquid Chromatography Tandem Mass Spectrometry Method.
Shipkova M; Rapp S; Rigo-Bonnin R; Wieland E; Peter A
Ther Drug Monit; 2017 Apr; 39(2):102-108. PubMed ID: 28125504
[TBL] [Abstract][Full Text] [Related]
19. Analytical performance of QMS everolimus assay on ortho Vitros 5,1 FS fusion analyzer: measuring everolimus trough levels for solid organ transplant recipients.
Shu I; Wright AM; Chandler WL; Bernard DW; Wang P
Ther Drug Monit; 2014 Apr; 36(2):264-8. PubMed ID: 24232125
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
